Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AXT Inc (AXTI) vs FMC Corp (FMC) Price & Performance

AXT IncTrade
FMC CorpTrade

Price performance (Past 24H)

Key statistics

AXT Inc vs FMC Corp — how do they compare? AXT Inc trades at $54.09 (market cap $3.77B), while FMC Corp trades at $10.73 (market cap $1.34B). The key difference: AXT Inc is far larger — about 2.8× FMC Corp's market cap, and FMC Corp pays a 2.99% dividend while AXT Inc pays none. Which is the better fit depends on your goals.

AXTIFMC
Market Cap
$3.77B$1.34B
Sector
TechnologyBasic Materials
52-Week High
$140.83$43.90
52-Week Low
$1.92$10.72
Enterprise Value
$3.73B$5.49B
Dividend Yield
2.99%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AXT Inc

AXTI trades at $50.46, down 11.8% in the past 24 hours, reflecting bearish technical signals and negative profitability metrics. The company reported a net loss of $21.26M in 2025 despite revenue of $88.33M, though 2026 projections show improved margins. Recent news highlights strong AI-driven demand for indium phosphide substrates and a $100M+ backlog, but export delays and cash flow risks remain concerns. Analyst consensus is bullish with 7 buy ratings, but technical indicators suggest near-term pressure.

The stock faces near-term headwinds from weak cash flow and high valuations (P/S 27.84), but long-term growth potential exists if AI demand materializes and capacity expansion executes smoothly. Key risks include geopolitical tensions affecting exports and execution challenges in scaling production. Investors should weigh the bullish analyst outlook against persistent fundamental weaknesses and technical bearishness.

FMC Corp

FMC Corporation (FMC) trades at $10.91 with no change in the latest session. The agricultural sciences company shows mixed signals with a bearish technical outlook but positive analyst sentiment (47.6% buy ratings). Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submissions for new herbicide technology. However, fundamental challenges persist with negative net income margin of -72.93% and declining revenue from $5.8B in 2022 to $3.47B in 2025.

The stock presents a turnaround opportunity with attractive valuation metrics (P/S 0.4x, P/B 0.75x) and significant upside to the $16 consensus price target. Key risks include continued revenue declines, negative cash flow from operations, and high debt levels. The company's strategic moves to reduce debt and advance new products could drive recovery if execution improves.

Returns comparison

Trailing returns across standard periods

About AXT Inc

AXT develops and manufactures high-performance compound semiconductor wafer substrates. Its products, like indium phosphide and gallium arsenide, are essential for data centers, 5G, and consumer electronics.

Read more on AXTI

About FMC Corp

FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.

Read more on FMC